EP Patent
EP2707508A4 — Hairy cell leukemia biomarkers and methods of using same
Assigned to Falini Brunangelo · Expires 2015-07-29 · 11y expired
What this patent protects
Patent listed against Zelboraf.
Drugs covered by this patent
- Zelboraf (vemurafenib) · Hoffmann La Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.